Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers"
- PMID: 32646619
- DOI: 10.1016/j.jhep.2020.05.031
Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers"
Conflict of interest statement
Conflicts of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.J Hepatol. 2020 Jul;73(1):121-129. doi: 10.1016/j.jhep.2020.03.005. Epub 2020 Mar 10. J Hepatol. 2020. PMID: 32165253
-
Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers.J Hepatol. 2020 Oct;73(4):972-973. doi: 10.1016/j.jhep.2020.05.018. Epub 2020 Aug 6. J Hepatol. 2020. PMID: 32771324 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
